Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
about
4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuseQuantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASBPharmacological treatment of anxiety disorders: current treatments and future directionsThe effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studiesSubstrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research.Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.[11C]-NS 4194 versus [11C]-DASB for PET imaging of serotonin transporters in living porcine brain.The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals.Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug usersInferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing.Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Preventing problems in Ecstasy users: reduce use to reduce harm.Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairmentMDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyA clinical crossroads for MDMA.The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.Chronic cognitive impairment in users of 'ecstasy' and cannabis.Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.The agony of ecstasy: responding to growing MDMA use among college students.Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.The P3 in 'ecstasy' polydrug users during response inhibition and execution.Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects.
P2860
Q24634712-90A71099-E029-4B3A-8473-D73D9F46E7E7Q24678394-7B6CCF37-17C2-49D0-87EC-CE20BAB3CF11Q26851461-528FADE2-55F0-494A-8762-83D64A2F1FBAQ28069364-3719B470-D414-4B45-BEB7-7B341320782BQ30561321-6EE1FA4F-25F3-4A64-B213-31340C204E70Q33637117-F08F7718-D7CF-4FA2-8FCD-3B1847B1AC55Q34025177-B4774BEC-458C-4E1E-A18E-4BBDD6D9EB71Q34190116-7888CFD1-7355-4C80-BAD4-2F03E363DA7BQ34201218-D1CD9C18-D199-4C4F-B88A-06A76607E57BQ34463526-CC629065-7AD6-4CE5-80E8-B01E90531281Q34618285-F6B097DA-5BAF-4859-9ACE-9C5276740DDDQ34634128-17D76A0B-64C6-498D-BAB5-2B7E41D24638Q34637364-DC0BFE25-8D8D-4692-97C3-00ACD607CA70Q34982523-F97A096C-1250-4BDF-AB6E-2D64F4B8B0FAQ35010538-F7C4B937-0107-47B3-935F-08BABD12BFB3Q35105557-00FC0A0C-092C-4BCD-B88D-4C4BC2461E40Q35158204-3DB87A26-1C3F-41FA-85FE-13C2C9C2A6A2Q35415158-A03A2B95-7D79-46FC-A86F-7E92A5D043CEQ36397237-DC123AB0-E5BB-49EA-8371-3D2BE976E42CQ36410792-D0BBE568-2B2C-4356-9FC7-727E2669A506Q36679249-C115A29E-0A95-4AE9-AA66-6ECE5F98ED74Q36691552-098A703B-E652-4C83-8E76-B0EAF426D444Q36831009-9BF2883C-F3C1-4B1D-B17B-004D4BAF696CQ36978299-F5B502B6-D619-4CA0-91FC-347E69F5997BQ37012610-9437D8C7-D92E-4E2E-B753-E0041D7541FEQ37461894-502AA57B-7218-4E44-87DA-3156A4F90370Q38376332-873D4E26-CEEA-4950-97FB-99F6BE26A937Q40007746-87F3EDDC-B0A5-4593-B9F2-BDDF9117FCA7Q40346595-E4D3FFC5-CC04-4CC9-AAF9-B75D17AB1AA1Q41848657-E72A60DB-8B16-47D3-AC7C-74DAA50BCBA0Q43096892-3AD83D99-EBEE-4399-B525-C93B40869177Q44153719-72399729-8B0D-4EF6-B7E1-1B82E8D48685Q44359164-76C29827-570B-4A4D-8D85-B517A046F0E7Q44363241-70D77F99-BBC2-46A1-B999-B19AA8807409Q45248986-5BFC8727-859E-4973-8D64-8482BF4B968DQ46477501-B72B7BA0-68E0-491A-AF04-5C57BADFDF19Q46705993-F7C7A150-E659-4E69-B994-7277D6327E76Q46970767-8084E698-C2ED-4F47-B5F0-6721D6B6D91BQ46970793-459199C8-B020-48E4-BD10-8C342CAB671DQ48248450-5E559A18-12F4-40EF-9664-60960A790D03
P2860
Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Cortical serotonin transporter ...... stasy"): preliminary findings.
@en
Cortical serotonin transporter ...... stasy"): preliminary findings.
@nl
type
label
Cortical serotonin transporter ...... stasy"): preliminary findings.
@en
Cortical serotonin transporter ...... stasy"): preliminary findings.
@nl
prefLabel
Cortical serotonin transporter ...... stasy"): preliminary findings.
@en
Cortical serotonin transporter ...... stasy"): preliminary findings.
@nl
P2093
P1433
P1476
Cortical serotonin transporter ...... stasy"): preliminary findings.
@en
P2093
Lavalaye J
de Wolff FA
den Heeten GJ
van den Brink W
P304
P356
10.1001/ARCHPSYC.58.10.901
P407
P577
2001-10-01T00:00:00Z